Literature DB >> 2039384

Retrospective postmortem dementia assessment. Validation of a new clinical interview to assist neuropathologic study.

P B Davis1, H White, J L Price, D McKeel, L N Robins.   

Abstract

Neuropathologic studies of dementia and normal aging suffer from a lack of individuals examined for the presence and severity of dementia before death. To increase clinical information in such cases, a retrospective collateral interview was developed. Thirty-nine individuals were studied; 27 had autopsies. In all cases, the autopsy confirmed the Retrospective Collateral Dementia Interview (RCDI) diagnosis of the presence or absence of dementia; the RCDI had a sensitivity of 88% and a specificity of 80% for specifically detecting probable Alzheimer's disease. Agreement between the RCDI and premortem diagnosis was 96%; between RCDI and medical records, 100%. Agreement between RCDI staging of dementia severity and the last assessment of the living subject was 70%; between the RCDI and a brief staging at death, 86%. This validation confirms the value of postmortem interviews with close informants to assess dementia presence and severity.

Entities:  

Mesh:

Year:  1991        PMID: 2039384     DOI: 10.1001/archneur.1991.00530180069019

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  18 in total

1.  Methionine Sulfoxide Reductase-B3 (MsrB3) Protein Associates with Synaptic Vesicles and its Expression Changes in the Hippocampi of Alzheimer's Disease Patients.

Authors:  Stephanie L Adams; Laurent Benayoun; Kathy Tilton; Olivia R Chavez; Jayandra J Himali; Jan Krzysztof Blusztajn; Sudha Seshadri; Ivana Delalle
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

2.  Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease.

Authors:  T Gómez-Isla; J L Price; D W McKeel; J C Morris; J H Growdon; B T Hyman
Journal:  J Neurosci       Date:  1996-07-15       Impact factor: 6.167

Review 3.  Utility of the clinical dementia rating in Asian populations.

Authors:  Wee Shiong Lim; Mei Sian Chong; Suresh Sahadevan
Journal:  Clin Med Res       Date:  2007-03

Review 4.  Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease.

Authors:  J C Morris; J L Price
Journal:  J Mol Neurosci       Date:  2001-10       Impact factor: 3.444

5.  Immunohistochemical Analysis of Activin Receptor-Like Kinase 1 (ACVRL1/ALK1) Expression in the Rat and Human Hippocampus: Decline in CA3 During Progression of Alzheimer's Disease.

Authors:  Stephanie L Adams; Laurent Benayoun; Kathy Tilton; Tiffany J Mellott; Sudha Seshadri; Jan Krzysztof Blusztajn; Ivana Delalle
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

6.  Variably Protease-sensitive Prionopathy in an Apparent Cognitively Normal 93-Year-Old.

Authors:  Nupur Ghoshal; Arie Perry; Daniel McKeel; Robert E Schmidt; Deborah Carter; Joanne Norton; Wen-Quan Zou; Xiangzhu Xiao; Gianfranco Puoti; Silvio Notari; Pierluigi Gambetti; John C Morris; Nigel J Cairns
Journal:  Alzheimer Dis Assoc Disord       Date:  2015 Apr-Jun       Impact factor: 2.703

7.  Increased expression of TrkB and Capzb2 accompanies preserved cognitive status in early Alzheimer disease pathology.

Authors:  Patricia F Kao; Meredith G Banigan; Charles R Vanderburg; Ann C McKee; Peter R Polgar; Sudha Seshadri; Ivana Delalle
Journal:  J Neuropathol Exp Neurol       Date:  2012-07       Impact factor: 3.685

8.  Clinical and radiological determinants of prestroke cognitive decline in a stroke cohort.

Authors:  T Pohjasvaara; R Mäntylä; H J Aronen; M Leskelä; O Salonen; M Kaste; T Erkinjuntti
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-12       Impact factor: 10.154

9.  Influence of cognitive impairment on the institutionalisation rate 3 years after a stroke.

Authors:  M Pasquini; D Leys; M Rousseaux; F Pasquier; H Hénon
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-09-04       Impact factor: 10.154

10.  Neurofibrillary tangle predominant form of senile dementia of Alzheimer type: a rare subtype in very old subjects.

Authors:  C Bancher; K A Jellinger
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.